Analysis of Cause-Specific Mortality in Patients with Retinoblastoma

Background. Retinoblastoma (RB) is a rare pediatric tumor with a relatively favorable prognosis. However, RB is associated with cause-specific mortality, some of that should be of great importance to clinicians. In this study, we summarize the characteristics of cause-specific mortality from nontumo...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Yang, Xiaolian Fang, Mei Jin, Jun Chen, Chengyue Zhang, Jianing Mou, Junyang Zhao, Xin Ni
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2022/2470890
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548640942456832
author Lei Yang
Xiaolian Fang
Mei Jin
Jun Chen
Chengyue Zhang
Jianing Mou
Junyang Zhao
Xin Ni
author_facet Lei Yang
Xiaolian Fang
Mei Jin
Jun Chen
Chengyue Zhang
Jianing Mou
Junyang Zhao
Xin Ni
author_sort Lei Yang
collection DOAJ
description Background. Retinoblastoma (RB) is a rare pediatric tumor with a relatively favorable prognosis. However, RB is associated with cause-specific mortality, some of that should be of great importance to clinicians. In this study, we summarize the characteristics of cause-specific mortality from nontumor disease in patients with RB. Methods. This retrospective case series study identified and analyzed cause-specific mortality in patients with RB. The information of cause-specific mortality of RB patients, including detailed clinical characteristics, diagnosis, treatment process, cause-specific mortality classification, and lag time, was assessed. Results. A total of 12 eligible patients were selected from 264 patients who died among 3780 patients diagnosed with RB. The cause-specific mortality rate was 4.5% for all patients with RB who died and 0.3% for all patients with RB. The main nontumor cause-specific mortalities were diseases of the nervous, circulatory, and respiratory systems, which specifically included intracranial infection, cerebral hemorrhage, paraplegia, and respiratory failure. The longest lag time was 42 days from the last chemoradiotherapy or surgery. Conclusion. Nontumor cause-specific mortality is an essential outcome of RB. Thus, intensive care and differentiation during management need to be taken seriously.
format Article
id doaj-art-da84fe6ad678414faa05942b21e99693
institution Kabale University
issn 2090-0058
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-da84fe6ad678414faa05942b21e996932025-02-03T06:13:36ZengWileyJournal of Ophthalmology2090-00582022-01-01202210.1155/2022/2470890Analysis of Cause-Specific Mortality in Patients with RetinoblastomaLei Yang0Xiaolian Fang1Mei Jin2Jun Chen3Chengyue Zhang4Jianing Mou5Junyang Zhao6Xin Ni7Department of OtolaryngologyDepartment of OtolaryngologyMedical Oncology DepartmentBeijing Engineering Research Center of Pediatric SurgeryDepartment of OphthalmologyDepartment of OtolaryngologyPediatric Oncology CenterDepartment of OtolaryngologyBackground. Retinoblastoma (RB) is a rare pediatric tumor with a relatively favorable prognosis. However, RB is associated with cause-specific mortality, some of that should be of great importance to clinicians. In this study, we summarize the characteristics of cause-specific mortality from nontumor disease in patients with RB. Methods. This retrospective case series study identified and analyzed cause-specific mortality in patients with RB. The information of cause-specific mortality of RB patients, including detailed clinical characteristics, diagnosis, treatment process, cause-specific mortality classification, and lag time, was assessed. Results. A total of 12 eligible patients were selected from 264 patients who died among 3780 patients diagnosed with RB. The cause-specific mortality rate was 4.5% for all patients with RB who died and 0.3% for all patients with RB. The main nontumor cause-specific mortalities were diseases of the nervous, circulatory, and respiratory systems, which specifically included intracranial infection, cerebral hemorrhage, paraplegia, and respiratory failure. The longest lag time was 42 days from the last chemoradiotherapy or surgery. Conclusion. Nontumor cause-specific mortality is an essential outcome of RB. Thus, intensive care and differentiation during management need to be taken seriously.http://dx.doi.org/10.1155/2022/2470890
spellingShingle Lei Yang
Xiaolian Fang
Mei Jin
Jun Chen
Chengyue Zhang
Jianing Mou
Junyang Zhao
Xin Ni
Analysis of Cause-Specific Mortality in Patients with Retinoblastoma
Journal of Ophthalmology
title Analysis of Cause-Specific Mortality in Patients with Retinoblastoma
title_full Analysis of Cause-Specific Mortality in Patients with Retinoblastoma
title_fullStr Analysis of Cause-Specific Mortality in Patients with Retinoblastoma
title_full_unstemmed Analysis of Cause-Specific Mortality in Patients with Retinoblastoma
title_short Analysis of Cause-Specific Mortality in Patients with Retinoblastoma
title_sort analysis of cause specific mortality in patients with retinoblastoma
url http://dx.doi.org/10.1155/2022/2470890
work_keys_str_mv AT leiyang analysisofcausespecificmortalityinpatientswithretinoblastoma
AT xiaolianfang analysisofcausespecificmortalityinpatientswithretinoblastoma
AT meijin analysisofcausespecificmortalityinpatientswithretinoblastoma
AT junchen analysisofcausespecificmortalityinpatientswithretinoblastoma
AT chengyuezhang analysisofcausespecificmortalityinpatientswithretinoblastoma
AT jianingmou analysisofcausespecificmortalityinpatientswithretinoblastoma
AT junyangzhao analysisofcausespecificmortalityinpatientswithretinoblastoma
AT xinni analysisofcausespecificmortalityinpatientswithretinoblastoma